Undergoing Interleukin-2 (IL-2) therapy within 8 weeks of study entry 
Diagnosed with a medical or psychiatric illness that may interfere with study participation 
Pregnant       
    

NCT00312429_exc_T1
Procedure
Interleukin-2 (IL-2) therapy
NCT00312429_exc_T2
Temporal
within 8 weeks of study entry
NCT00312429_exc_T3
Condition
illness that may interfere with study participation medical
NCT00312429_exc_T4
Condition
psychiatric illness that may interfere with study participation
NCT00312429_exc_T5
Condition
Pregnant